Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

By P. Marckmann, L. Skov, K. Rossen, A. Dupont, M. Damholt, J. Heaf, H. Thomsen. Journal of the American Society of Nephrology, 2006

1,334 citations recorded by the source corpus.

Subfields: Materials Chemistry, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/f1e47dc87a2e14441452ce63165ff80d25e5768f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Kanal
2. A. Barkovich
3. C. Bell
4. J. Borgstede
5. James W. Lester
6. Ellisa Kuhni-Kaminski
7. William G. Bradley
8. Jerry W. Froelich

Citations in the corpus

• ACR guidance document for safe MR practices: 2007. (2007, background): “The association with gadolinium-based MR contrast agents (GBMCAs): Besides the initial reports noted above, in August 2, 2006, researchers from the Copenhagen University Hospital in Denmark published in the Journal of the American Society of Nephrology [40] the results of their review of all 13 conf”